ロード中...
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore cephalosporin that combines a catechol-type siderophore and cephalosporin core with side chains similar to cefepime and ceftazidime. This structure and its unique mechanism of action confer enhanced stability against...
保存先:
| 出版年: | Infect Dis Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7054475/ https://ncbi.nlm.nih.gov/pubmed/32072491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00286-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|